Miss Emma Swift
Teams and roles for Emma Swift
Publication
2025
- Lovatt, C., Frängsmyr, L., Swift, E. A., Mundy, R. M. and Parker, A. L. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23(10), pp. 3319-3326. (10.1016/j.jtha.2025.06.006)
- Swift, E. A. and Parker, A. L. 2025. Adenoviral vector targeting. In: Curiel, D. T. and Parker, A. L. eds. Adenoviral Vectors for Gene Therapy. Elsevier, pp. 365-401., (10.1016/B978-0-323-89821-8.00017-6)
2022
Articles
- Lovatt, C., Frängsmyr, L., Swift, E. A., Mundy, R. M. and Parker, A. L. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23(10), pp. 3319-3326. (10.1016/j.jtha.2025.06.006)
- Swift, E. A., Pollard, S. M. and Parker, A. L. 2022. Engineering cancer selective virotherapies: are the pieces of the puzzle falling into place?. Human Gene Therapy 33(21-22) (10.1089/hum.2022.178)
Book sections